Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076374 · ClinicalTrials.gov registry record
MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY
A clinical trial of Bradycardia and Arrhythmia, sponsored by Medtronic.
- Completed
- Registry status
- 2,927
- Enrollment target
- 20
- Study locations
NCT01076374: Completed study of Bradycardia and Arrhythmia, sponsored by Medtronic.
NCT01076374 is a study of Bradycardia and Arrhythmia that has completed, run by Medtronic. The registered enrollment target is 2,927 participants, below the 4,312-participant average among 29 other Bradycardia trials with a reported enrollment target (32% lower). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01076374, a study of Bradycardia and Arrhythmia, has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 2,927 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary purpose of this study is to assess the long term reliability of the Medtronic Adapta®/Sensia™/Versa™ platform of devices. This study is required by FDA as a condition of approval of nEw3 devices. Patients will be followed for 5 years after implant. This study utilizes data collected from the System Longevity Study (SLS).
Conditions Studied
Study Locations (20)
California
- - Bakersfield
- - Chula Vista
- - Downey
- - East Palo Alto
- - La Jolla
- - Long Beach
- - Los Angeles
- - Redding
- - Salinas
- - San Diego
- - Santa Rosa
- - Torrance
- - Van Nuys
Arizona
- - Gilbert
- - Scottsdale
Arkansas
- - Jonesboro
- - Little Rock
Alabama
- - Birmingham
Alaska
- - Anchorage
Colorado
- - Colorado Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,927 participants |
| Start Date | 2008-07 |
| Est. Completion | 2015-12 |
What the finished NCT01076374 record still lists
NCT01076374 is an observational study that tracks outcomes without assigning an intervention. Its 2,927 participants enrollment target places it among the larger protocols in the corpus, below the 4,312-participant average among 29 other Bradycardia trials with a reported enrollment target (32% lower).
The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 0 interventions.
NCT01076374 names 20 study sites across 6 states, led by California, Arizona, Arkansas.
Frequently Asked Questions
What is clinical trial NCT01076374 about?
NCT01076374 is a clinical study titled "MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY". The primary purpose of this study is to assess the long term reliability of the Medtronic Adapta®/Sensia™/Versa™ platform of devices. This study is required by FDA as a condition of approval of nEw3 devices. Patients will be followed for 5 years after implant. This study utilizes data collected from...
What is the current status of trial NCT01076374?
This trial is currently completed. The enrollment target is 2,927 participants. The study started on 2008-07. Estimated completion is 2015-12.
What conditions does trial NCT01076374 study?
This clinical trial studies the following conditions: Bradycardia, Arrhythmia.
Who is sponsoring clinical trial NCT01076374?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01076374 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01076374's enrollment target sits among peer trials
2,927 7th of 29 higher than 23 of 29 other Bradycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Aveir VR Real-World Evidence Post-Approval Study
RECRUITING
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
The Alaska Oculocardiac Reflex Study
RECRUITING
-
His Bundle Pacing in Bradycardia and Heart Failure
RECRUITING
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05849961 · 2,946 participants
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
- NCT03331380 · 2,950 participants · NA
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NCT07222995 · 2,900 participants · NA
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia